BRCA Testing Recommendations Based on Age and Family History
BRCA testing should be considered for individuals with a strong family history of breast and ovarian cancer starting at age 25, or 5-10 years before the earliest known breast cancer diagnosis in the family, whichever comes first. 1
Who Should Be Tested for BRCA Mutations
BRCA testing is recommended for:
Individuals with a personal history of:
Individuals with family history of:
Specific high-risk populations:
- Individuals from families meeting Li-Fraumeni syndrome criteria 1
- Women with breast cancer aged <30 years with a negative BRCA1/2 test, especially with family history of sarcoma, brain tumor, or adrenocortical carcinoma 1
- Individuals with a combined BRCA1 and BRCA2 mutation carrier probability of 10% or more 1
Age-Based Testing Recommendations
- Age 18: Begin breast self-awareness education and monthly practice for those at high risk 1
- Age 20-25: Begin clinical breast examinations every 6-12 months for high-risk individuals 1
- Age 25-29: Consider BRCA testing if family history criteria are met; begin annual breast MRI screening with contrast for those who test positive 1
- Age 30-75: Annual mammogram and breast MRI with contrast for those who test positive 1
- After age 75: Individualized management based on health status and risk factors 1
Risk Stratification
The risk of carrying a BRCA mutation increases significantly with:
- Younger age at breast cancer diagnosis (particularly <45 years) 3
- Multiple affected family members 4
- Presence of both breast and ovarian cancer in the family 1
- Bilateral breast cancer 1
- Male breast cancer 2
- Ashkenazi Jewish ancestry 1
Important Considerations and Pitfalls
Don't delay primary treatment for genetic counseling referral - Testing can be arranged concurrently with treatment planning 1
Consider mutation location - Breast cancer risk varies based on the location of mutations within BRCA1/2 genes 4
Family history on both sides matters - Paternal family history is equally important but often overlooked 2
Testing negative doesn't eliminate risk - Women with significant family history who test negative still have approximately four-fold increased risk of breast cancer 5
Different outcomes by mutation type - BRCA1 carriers have worse outcomes even when tumors are diagnosed early, compared to BRCA2 carriers 6
Age trumps family history in practice - Studies show younger patients are more likely to receive testing even when older patients with strong family history have similar mutation probability 3
By following these evidence-based recommendations for BRCA testing, clinicians can identify high-risk individuals who may benefit from enhanced surveillance and risk-reducing interventions, ultimately improving morbidity, mortality, and quality of life outcomes.